Head-To-Head Contrast: Varian Medical Systems (VAR) and Boston Scientific (BSX)
Varian Medical Systems (NYSE: VAR) and Boston Scientific (NYSE:BSX) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.
Insider & Institutional Ownership
99.2% of Varian Medical Systems shares are held by institutional investors. Comparatively, 91.9% of Boston Scientific shares are held by institutional investors. 0.8% of Varian Medical Systems shares are held by insiders. Comparatively, 0.7% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
This table compares Varian Medical Systems and Boston Scientific’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Varian Medical Systems||$2.67 billion||4.29||$249.60 million||$3.65||34.38|
|Boston Scientific||$9.05 billion||4.32||$105.00 million||$0.70||40.61|
Varian Medical Systems has higher earnings, but lower revenue than Boston Scientific. Varian Medical Systems is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.
This is a summary of recent ratings and price targets for Varian Medical Systems and Boston Scientific, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Varian Medical Systems||3||5||3||0||2.00|
Varian Medical Systems presently has a consensus price target of $108.44, indicating a potential downside of 13.58%. Boston Scientific has a consensus price target of $30.94, indicating a potential upside of 8.82%. Given Boston Scientific’s stronger consensus rating and higher probable upside, analysts plainly believe Boston Scientific is more favorable than Varian Medical Systems.
This table compares Varian Medical Systems and Boston Scientific’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Varian Medical Systems||4.27%||27.13%||11.95%|
Volatility & Risk
Varian Medical Systems has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500.
Varian Medical Systems beats Boston Scientific on 8 of the 15 factors compared between the two stocks.
About Varian Medical Systems
Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.
About Boston Scientific
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.